| Literature DB >> 31878170 |
Fernanda Faria1, Cheryl Howe2, Ricardo Faria3, Alynne Andaki4, João Carlos Marins1, Paulo Roberto Amorim1.
Abstract
We investigated the impact of a sports activities program on metabolic syndrome (MetS) components and pre-MetS among adolescents. Blood samples, blood pressure, weight, height, body mass index, waist circumference, body fat percentage, frequency of food consumption, daily time in moderate-to-vigorous physical activity (MVPA), and sedentary behavior (SB) of 92 male adolescents aged 14-18 years (16.07 ± 0.93) were evaluated. From this initial sample, 36 participants (39.1%) were diagnosed with pre-MetS or MetS and were invited to participate in the intervention program. Twelve individuals diagnosed with pre-MetS or MetS agreed to participate in a recreational sports activities program lasting 14 weeks. The pre- and post-sport program comparison showed a reduction in total cholesterol, low-density lipoprotein, and non-high-density lipoprotein (HDL), and an increase in HDL and MVPA time in the intervention group. Sports activities accounted for 42% of the MVPA daily recommendation, and at the end of the intervention period, only seven subjects maintained a positive diagnosis for pre-MetS or MetS. This study showed that recreational sports activities had a significant impact on the lipid profile.Entities:
Keywords: accelerometer; adolescent; lifestyle; metabolic syndrome; obesity
Mesh:
Year: 2019 PMID: 31878170 PMCID: PMC6981663 DOI: 10.3390/ijerph17010143
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Participants’ metabolic, anthropometric, and hemodynamic profile, with and without metabolic syndrome or pre-metabolic syndrome.
| Variables | Total | No Pre-MetS or MetS (n = 56) | Pre-MetS or MetS (n = 36) | ES | |
|---|---|---|---|---|---|
| Age (years) * | 16.0 (14.0–18.0) | 16.0 (14.0–18.0) | 16.0 (14.0–18.0) | 0.287 | 0.11 |
| Weight (kg) * | 61.3 (39.1–105) | 60.6 (39.1–84.1) | 65.1 (48.8–105) | 0.004 † | 0.30 |
| Height (m) | 1.74 (±0.06) | 1.73 (±0.06) | 1.75 (±0.06) | 0.214 | 0.33 |
| BMI (kg/m2) * | 20.5 (15.1–33.9) | 20.2 (15.1–25.1) | 21.2 (16.8–33.9) | 0.021 † | 0.24 |
| WHtR * | 0.4 (0.36–0.56) | 0.4 (0.36–0.5) | 0.41 (0.36–0.56) | 0.139 | 0.15 |
| BF%* | 13.4 (7.2–41.4) | 13.5 (7.9–26.6) | 12.5 (7.2–41.4) | 0.914 | 0.01 |
| MWC (cm) * | 72.1 (63.0–99.4) | 71.7 (63.0–86.8) | 74.7 (64.5–99.4) | 0.030 † | 0.23 |
| SWC (cm) * | 71.4 (61.4–97.1) | 70.9 (61.4–84.0) | 73.0 (63.6–97.1) | 0.025 † | 0.23 |
| SBP (mmHg) | 111.6 (±10.8) | 109.1 (±10.2) | 115.5 (±10.7) | 0.005 † | 0.61 |
| DBP(mmHg) | 72.5 (±7.7) | 70.5 (±7.3) | 75.6 (±7.3) | 0.002 † | 0.70 |
| HDL (mg/dL) | 42.9 (±8.6) | 45.8 (±8.9) | 38.3 (±5.9) | 0.000 ‡ | 1.00 |
| TG (mg/dL) * | 85 (36–288) | 75.5 (36–110) | 111 (65–288) | 0.000 ‡ | 0.64 |
| FG (mg/dL) | 77.8 (±7.5) | 77.1 (±7.1) | 78.9 (±8.0) | 0.248 | 0.25 |
| Insulin (mU/L) * | 4.8 (1.4–28.5) | 4.4 (1.4–21.0) | 6.09 (1.9–28.5) | 0.049 † | 0.21 |
| HOMA-IR * | 0.98 (0.27–5.44) | 0.85 (0.27–4.58) | 1.13 (0.36–5.44) | 0.045 † | 0.21 |
| TC (mg/dL) | 159.6 (±23.6) | 155.4 (±22.8) | 166.2 (±23.5) | 0.031 † | 0.47 |
| LDL (mg/dL) | 97.6 (±19.4) | 94.4 (±18.3) | 102.6 (±20.4) | 0.048 † | 0.42 |
| Non-HDL | 116.7 (±22.6) | 109.5 (±19.4) | 127.8 (±23.1) | 0.000 ‡ | 0.86 |
†p < 0.05; ‡ p < 0.001. Note: BMI = body mass index; WHtR = waist-to-height ratio; BF% = body fat %; MWC = midpoint waist circumference; SWC = smallest waist circumference; SBP = systolic blood pressure; DBP = diastolic blood pressure; HDL = high-density lipoprotein; TG = triglycerides; FG = fasting glucose; HOMA-IR = Homeostatic Model Assessment; TC = total cholesterol; LDL = low density lipoprotein; Non-HDL = not HDL cholesterol; MetS = metabolic syndrome; ES = effect size. * Variables expressed as median (minimum and maximum); other variables: average (± standard deviation).
Description of physical activity variables within physical and energy expenditure.
| Variables | n | Total Sample | n | No Pre-MetS or MetS | n | Pre-MetS or MetS | ES | |
|---|---|---|---|---|---|---|---|---|
| MVPA (min/week) | 83 | 70.3 (±19.8) | 51 | 71.4 (±21.3) | 32 | 68.6 (±17.2) | 0.54 | 0.14 |
| MVPA (min/weekday) | 83 | 76.5 (±20.8) | 51 | 77.3 (±22.0) | 32 | 75.3 (±19.2) | 0.67 | 0.10 |
| MVPA (min/weekend day) * | 80 | 48.5 (1.5–149.5) | 49 | 51.5 (1.5–149.5) | 31 | 48 (4.5–113) | 0.61 | 0.05 |
| TEE (kcal/day) | 83 | 3095 (±582) | 51 | 3004 (±472) | 32 | 3240 (±708) | 0.11 | 0.40 |
| BMR (kcal/day) * | 92 | 1743 (1350–2516) | 56 | 1730 (1350–2145) | 36 | 1810 (1521–2516) | 0.004 † | 0.30 |
†p < 0.01. Note: MVPA = moderate-to-vigorous physical activity; TEE = total energy expenditure; BMR = basal metabolic rate; MetS = metabolic syndrome; ES = effect size. * Variables expressed as median (minimum and maximum); other variables: mean (± standard deviation).
Association between anthropometric indicators of obesity and metabolic variables in male adolescents (n = 92).
| Variables | MWC | SWC | BF% | BMI | WHtR | |
|---|---|---|---|---|---|---|
| HDL | β | −0.428 † | −0.487 † | −0.129 | −0.860 † | 53.344 ‡ |
| SBP | β | 0.604 † | 0.670 † | 0.535 † | 1.601 † | 93.779 † |
| DBP | β | 0.335 † | 0.391 † | 0.234 ‡ | 0.996 † | 59.009 † |
| BMI ** | β | 0.007 † | 0.008 † | 0.006 † | –– | 1.384 † |
†p < 0.001. ‡ p < 0.05. ** Transformed into a log. Note: HDL = high-density lipoprotein; SBP = systolic blood pressure; DBP = diastolic blood pressure; BMI = body mass index; MWC = midpoint waist circumference; SWC = smallest waist circumference; BF% = body fat %; WHtR = waist-to-height ratio.
Anthropometric and metabolic variables at pre- and post-intervention (n = 12).
| Variables | Pre- | Post- | ES | |
|---|---|---|---|---|
| WHtR * | 0.42 (0.39–0.56) | 0.42 (0.37–0.53) | 0.071 | 0.36 |
| BF% | 18.11 (±10.25) | 18.31 (±9.72) | 0.771 | 0.02 |
| MWC (cm) * | 74.47 (67.5–99.0) | 72.57 (69.1–92.8) | 0.875 | 0.03 |
| SWC (cm) | 75.17 (±7.55) | 75.09 (±7.14) | 0.896 | 0.01 |
| SBP (mmHg) | 114.5 (±12.19) | 111.25 (±10.2) | 0.082 | 0.29 |
| DBP (mmHg) | 75.41 (±8.37) | 76.0 (±6.79) | 0.737 | 0.07 |
| HDL (mg/dL) | 38.53 (±6.19) | 52.10 (±14.25) | 0.004 † | 1.30 |
| TG (mg/dL) * | 101.0 (65.0–286.0) | 77.6 (49.0–112.5) | 0.117 | 0.31 |
| FG (mg/dL) | 78.02 (±8.55) | 83.86 (±5.92) | 0.005 | 0.81 |
| Insulin (mU/L) * | 5.91 (1.91–25.4) | 6.90 (2.58–19.7) | 0.347 | 0.19 |
| HOMA-IR * | 1.12 (0.36–4.35) | 1.35 (0.6–3.95) | 0.638 | 0.09 |
| TC (mg/dL) | 164.01 (±27.18) | 148.01 (±24.2) | 0.024 † | 0.62 |
| LDL (mg/dL) | 103.76 (±24.44) | 79.68 (±19.53) | 0.002 † | 1.1 |
| Non-HDL | 125.48 (±26.96) | 95.90 (±21.83) | 0.001 † | 1.2 |
†p < 0.05. Note: BMI = body mass index; WHtR = waist-to-height ratio; BF% = body fat %; MWC = midpoint waist circumference; SWC = smallest waist circumference; SBP = systolic blood pressure; DBP = diastolic blood pressure; HDL = high-density lipoprotein; TG = triglycerides; FG = fasting glucose; HOMA-IR = Homeostatic Model Assessment; TC = total cholesterol; LDL = low density lipoprotein; Non-HDL = not HDL cholesterol; ES = effect size. * Variables expressed as median (minimum and maximum); other variables: average (± standard deviation).
Energy expenditure, physical activity, and sedentary behavior before and during the intervention period.
| Variables | n | Pre- | Post- | ES | |
|---|---|---|---|---|---|
| TEE (kcal/day) | 11 | 2963 (2511–4423) | 3494 (2886–4752) | 0.010 † | 0.55 |
| BMR (kcal/day) * | 12 | 1822 (±212) | 1837 (±203) | 0.164 | 0.07 |
| MVPA | |||||
| min/day * | 11 | 72.5 (56.5–108.5) | 81.4 (73–137) | 0.016† | 0.51 |
| min/weekday | 11 | 88 (±19.9) | 100.6 (± 19.5) | 0.070 | 0.64 |
| min/weekend day * | 10 | 50.4 (±27.6) | 39.9 (± 29.8) | 0.291 | 0.37 |
| SB | |||||
| min/week * | 11 | 598.4 (492.7–673.3) | 587.8 (498–922.6) | 0.929 | 0.01 |
| min/weekday * | 11 | 650.2 (464–682.6) | 596.7 (488.8–1054) | 0.929 | 0.01 |
| min/weekend day * | 9 | 520.5 (380–668.5) | 498 (265–552) | 0.594 | 0.13 |
†p < 0.05. Note: TEE = total energy expenditure; BMR = basal metabolic rate; MVPA = moderate-to-vigorous physical activity; SB = sedentary behavior; ES = effect size. * Variables expressed as median (minimum and maximum); other variables: mean (±standard deviation).
Figure 1Changes in metabolic syndrome components in adolescents before and after 14 weeks of intervention.